Medivent International, The future of respiratory technology
Hayek RTX
Medivent RTX
Features and Benefits
The Hayek RTX Respirators in many cases offers a REAL non-invasive alternative to Positive Pressure Ventilation (PPV) as it can provide complete ventilation, unlike other non-invasive ventilators:
The only respirator that automatically expels secretions, clearing the lungs.
The only respirator that is fully physiological, increasing the patient's cardiac output.
Treatment can be administered either in hospital or the home.
Improved patient care: The RTX has been shown to reduce mortality rates, increase patient comfort, and avoid many harmful side-effects associated with existing respiratory techniques.
Significant Cost-savings: Unique operating method reduces hospitalization rates, time in ICU. Ease-of-use reduces dependency on highly specialized staff.
Technical and Physical Specifications
Frequency: 6-1200 cycles per minute
I/E Ratio: 1:6 - 6:1
Maximum Inspiratory Pressure: -50 cmH20
Maximum Expiratory Pressure: +50 cmH20
Power Unit Weight: 9kg
Dimensions: 370 x 260 x 180mm (W x D x H)
Cuirasses: 4 Adult Sizes, 7 Paediatric sizes
The Hayek RTX Respirator provides an efficient and effective method of non-invasive external ventilation and can be a real alternative to traditional forms of ventilation. The RTX actively controls the inspiratory and expiratory phases of respiration (using BCV), making the device work physiologically and successfully.

Compact and lightweight, the RTX Respirator is ideally suited for use in both acute and chronic, intubated or non-intubated patients.

Using the various trigger modes, the RTX Respirator may be synchronised to the patient's own respiratory or cardiac cycles.

Implementing exhalation during systole and inhalation during diastole, using the revolutionary new ECG Triggered Mode, has allowed the Hayek RTX Respirator to open new avenues in the field of cardiac assistance, an area not previously associated with ventilatory technology.

The Hayek RTX is a user-friendly, fully computerised device, which has eleven sizes of cuirass enabling treatment of both adult and paediatric patients.
Patient Groups
BCV has been successfully used on patients with:
Acute Respiratory Failure
Chronic Obstructive Pulmonary Disease (COPD)
Neuromuscular (e.g. SMA, Duchennes etc)
Head and Spinal Injuries
Problems with Weaning from PPV
Ventilation during anaesthesia in Ear Nose and Throat (ENT) Procedures
Cystic Fibrosis (CF), and those who require physiotherapy
Aids Related Lung Disease
Asthma
Ventilation post-operation Eg. post-coronary bypass, Fontan, Fallot, post-pneumonectomy
Modes of Operation
Continuous Negative (CNEP)
Controlled ( Mandatory Controlled Ventilation )
Respiratory Synchronised
Secretion Clearance
Currently unavailable in the USA